$146M Deal In Aggrenox Pay-For-Delay MDL Gets Initial OK
A Connecticut federal judge on Tuesday preliminarily approved a $146 million settlement between direct purchasers and pharmaceutical companies over the drugmakers' alleged role in a scheme to block generic alternatives to...To view the full article, register now.
Already a subscriber? Click here to view full article